Advertisements



Opioid maker Insys to be delisted from NASDAQ following bankruptcy filing

Opioid maker Insys Therapeutics, Inc. shares will be delisted on the Nasdaq on June 19, the company said in a government filing on Tuesday......»»

Category: topSource: moneycentralJun 12th, 2019

Opioid maker Insys to be delisted from NASDAQ following bankruptcy filing

Opioid maker Insys Therapeutics, Inc. shares will be delisted on the Nasdaq on June 19, the company said in a government filing on Tuesday......»»

Category: topSource: moneycentralJun 12th, 2019

Chandler opioid maker files for bankruptcy protection

A troubled Chandler-based pharmaceutical firm that has been at the center of ongoing lawsuits and other action related to the national opioid epidemic has filed for bankruptcy protection. In a regulatory filing Monday, Insys Therapeutics (Nasdaq: .....»»

Category: topSource: bizjournalsJun 10th, 2019

What Insys Therapeutics Gets by Filing for Chapter 11

Fentanyl-maker Insys Therapeutics has filed for bankruptcy protection while the company sells all its assets......»»

Category: blogSource: 247wallstJun 10th, 2019

Opioid maker Insys Therapeutics files Chapter 11 bankruptcy after corruption charges

Pharmaceutical company Insys Therapeutics filed for Chapter 11 bankruptcy protection Monday less than a week after pleading .....»»

Category: topSource: usatodayJun 10th, 2019

Insys Shares Fall 70% After Filing For Chapter 11 Bankruptcy

Insys Therapeutics, Inc. (NASDAQ: INSY) shares are trading sharply lower following news the company initiated a court supervised process to facilitate asset sales via Chapter 11 bankruptcy. read more.....»»

Category: blogSource: benzingaJun 10th, 2019

Insys Plunges 70% After Bankruptcy Warning

Opioid drugmaker Insys Therapeutics Inc (NASDAQ: INSY) may soon go bust, the company suggested in the first-quarter earnings report it released Friday after the close. read more.....»»

Category: blogSource: benzingaMay 13th, 2019

Insys stock drops 27% after auditor questions company"s viability

Shares of opioid maker Insys Therapeutics Inc. dropped 27% on Wednesday after the company disclosed in a securities filing that an audito.....»»

Category: topSource: marketwatchMar 13th, 2019

Legacy Reserves Shares Trading For Pennies After Chapter 11 Bankruptcy Filing

Legacy Reserves Inc (NASDAQ: LGCY) has made a Chapter 11 filing in the U.S. Bankruptcy Court for the Southern District of Texas. read more.....»»

Category: blogSource: benzingaJun 19th, 2019

Insys is first drugmaker to file for bankruptcy to cover opioid penalties

The moves comes one week after the company agreed to pay $225 million to resolve a federal investigation into a bribery scheme designed to induce doctors to overprescribe a fentanyl spray......»»

Category: topSource: washpostJun 10th, 2019

Insys becomes first drugmaker to file for bankruptcy to cover opioid penalties

The moves comes one week after the company agreed to pay $225 million to resolve a federal investigation into a bribery scheme designed to induce doctors to overprescribe a fentanyl spray......»»

Category: topSource: washpostJun 10th, 2019

Opioid manufacturer Insys files for bankruptcy after kickback probe

Drugmaker Insys Therapeutics Inc filed for bankruptcy protection on Monday amid mounting expenses driven by a U.S. Justice Department probe into claims it paid doctors bribes to prescribe a powerful opioid medication......»»

Category: topSource: reutersJun 10th, 2019

The Wall Street Journal: Insys files for Chapter 11 days after settling opioid case

Specialty-pharmaceutical company Insys Therapeutics Inc. filed for chapter 11 bankruptcy with plans to sell its assets, just days after agreeing to pay $225 million to settle federal charges over sales of its opioid drug Subsys......»»

Category: topSource: marketwatchJun 10th, 2019

Opioid drugmaker Insys Therapeutics files for bankruptcy

Opioid drugmaker Insys Therapeutics files for bankruptcy.....»»

Category: topSource: foxnewsJun 10th, 2019

Opioid drugmaker Insys Therapeutics files for bankruptcy

Drugmaker Insys Therapeutics Inc filed for Chapter 11 bankruptcy protection on Monday, about a week after agreeing to pay $225 million to settle a U.S. probe into bribes it paid to doctors for prescribing a powerful opioid medication......»»

Category: topSource: reutersJun 10th, 2019

Insys bankruptcy could complicate $225M opioid settlement with DOJ, WSJ says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 7th, 2019

Insys Plunges 70% After Bankruptcy Warning

Opioid drugmaker Insy.....»»

Category: earningsSource: benzingaMay 13th, 2019

Drugmaker Insys shares tank after saying opioid lawsuits may force it into bankruptcy

Insys Th.....»»

Category: topSource: moneycentralMay 13th, 2019

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs

Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»

Category: earningsSource: benzingaApr 21st, 2019

Achaogen"s Bankruptcy Filing, Proposed Sale: What You Need to Know

Nanocap biotech Achaogen Inc (NASDAQ: AKAO) has been pushed to the brink, with the company announcing Monday that it has voluntarily filed for Chapter 11 bankruptcy read more.....»»

Category: blogSource: benzingaApr 15th, 2019

Nasdaq Delists Long Island Blockchain

Long Blockchain, a company that pivoted from being a beverage maker to a blockchain technology provider, is being delisted from the Nasdaq effective Thursday......»»

Category: blogSource: 247wallstApr 11th, 2018